section name header

Y-Site Injection Compatibility (1:1 Mixture)

Octreotide acetate

(Mfr: APP, FRK)(Conc: 4 mcg/mLe)

C

Ceftolozane sulfate-tazobactam sodium

(Mfr: CUB)(Conc: 10 mg/mLe,f)

Remarks:

Physically compatible for 2 hr

Ref:

3262